This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Bayer, Tevra spar over motion to exclude plaintiff expert damages testimony in US antitrust case over flea, tick treatments

( July 17, 2024, 18:53 GMT | Official Statement) -- MLex Summary: Tevra is attempting to "substitute in an entirely new expert methodology that doubles Tevra’s damages claim, without disclosing any of the data, assumptions, or methods underlying it," Bayer told a US federal judge hearing an antitrust case accusing the chemical giant of engaging in two separate schemes of illegal exclusive dealing and illegal tying involving Imidacloprid topical flea and tick treatments. Bayer "woke up and chose violence" by putting forward "professionally vulgar allegations" that lack substance, Tevra said in a separate motion filed in the Northern District of California opposing Bayer's emergency motion to exclude the damages testimony of Robert Scharf.See documents below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections